Ikena Oncology, Inc.
NASDAQ:IKNA
1.71 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 119.894 | 59.919 | 232.217 | 162.491 | 82.083 | 18.156 |
| Short Term Investments
| 55.571 | 97.028 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 175.465 | 156.947 | 232.217 | 162.491 | 82.083 | 18.156 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.197 | 0.964 | 0.629 | 1.561 | 1.266 | 1.824 |
| Total Current Assets
| 178.662 | 160.01 | 236.516 | 165.969 | 85.205 | 19.98 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 8.021 | 8.46 | 8.977 | 1.563 | 0.769 | 0.696 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.278 | 0.872 | 2.386 | 0.872 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.131 | 2.917 | 0 | 0 | -0.769 | -0 |
| Total Non-Current Assets
| 13.43 | 12.249 | 11.363 | 2.435 | 0.769 | 0.696 |
| Total Assets
| 192.092 | 172.259 | 247.879 | 168.404 | 85.974 | 20.676 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.066 | 2.093 | 2.384 | 2.122 | 0.935 | 2.267 |
| Short Term Debt
| 3.558 | 1.907 | 1.851 | 0.186 | 2.558 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 9.16 | 17.1 | 20.622 | 20.683 | 0.126 |
| Other Current Liabilities
| 8.581 | 8.343 | 5.854 | 5.402 | 0.121 | 1.431 |
| Total Current Liabilities
| 14.205 | 21.503 | 27.189 | 28.332 | 24.297 | 3.824 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 7.18 | 3.787 | 5.135 | 205.979 | 78.867 | 62.576 |
| Deferred Revenue Non-Current
| 0 | 0 | 7.678 | 35.141 | 44.273 | 0.116 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -7.678 | -205.979 | -78.867 | 0 |
| Other Non-Current Liabilities
| 0.95 | 0 | 7.678 | 205.979 | 78.867 | 0 |
| Total Non-Current Liabilities
| 8.13 | 3.787 | 12.813 | 241.12 | 123.14 | 62.692 |
| Total Liabilities
| 22.335 | 25.29 | 40.002 | 269.452 | 147.437 | 66.516 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 247.879 | 205.979 | 78.867 | 62.576 |
| Common Stock
| 0.048 | 0.036 | 0.036 | 0.003 | 0.003 | 0.019 |
| Retained Earnings
| -282.385 | -214.219 | -145.454 | -111.339 | -67.083 | -50.266 |
| Accumulated Other Comprehensive Income/Loss
| -0.048 | -0.763 | -247.879 | -205.979 | -78.867 | -0 |
| Other Total Stockholders Equity
| 452.142 | 361.915 | 353.295 | 10.288 | 5.617 | -58.169 |
| Total Shareholders Equity
| 169.757 | 146.969 | 207.877 | -101.048 | -61.463 | -45.84 |
| Total Equity
| 169.757 | 146.969 | 207.877 | -101.048 | -61.463 | -45.84 |
| Total Liabilities & Shareholders Equity
| 192.092 | 172.259 | 247.879 | 168.404 | 85.974 | 20.676 |